On November 16, 2020 Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company advancing proprietary intranasal vaccines and peptide therapeutics for liver disease, reported that management will present at the following upcoming virtual investor conferences (Press release, Altimmune, NOV 16, 2020, View Source [SID1234571147]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies London Virtual Healthcare Conference
Tuesday, November 17, 2020
11:25 am Eastern Time

Piper Sandler 32nd Annual Virtual Healthcare Conference
Monday, November 23, 2020 to Thursday, December 3, 2020
Fireside chat recording available to conference participants

3rd Annual Evercore ISI Virtual HealthCONx Conference
Wednesday, December 2, 2020
8:00 am Eastern Time

The sessions will be webcast and can be accessed by visiting the investor relations section of the company’s website at www.altimmune.com under Events / Presentations.